Detection of Pathognomonic Biomarker PrPSc and the Contribution of Cell Free-Amplification Techniques to the Diagnosis of Prion Diseases
Authors:
- Hasier ErañaHEHasier Eraña
- Jorge M. CharcoJCJorge M. Charco
- Ezequiel González-MirandaEGEzequiel González-Miranda
- Sandra García-MartínezSGSandra García-Martínez
- Rafael López-MorenoRLRafael López-Moreno
- Miguel A. Pérez-CastroMPMiguel A. Pérez-Castro
- Carlos M. Díaz-DomínguezCDCarlos M. Díaz-Domínguez
- Adrián García-SalvadorAGAdrián García-Salvador
- Joaquín CastillaJoaquín Castilla
Open Access
- 19 March 2020
- journal article
- review article
- Published by MDPI AG in Biomolecules
- Vol. 10 (3) , 469
Abstract
Transmissible spongiform encephalopathies or prion diseases are rapidly progressive neurodegenerative diseases, the clinical manifestation of which can resemble other promptly evolving neurological maladies. Therefore, the unequivocal ante-mortem diagnosis is highly challenging and was only possible by histopathological and immunohistochemical analysis of the brain at necropsy. Although surrogate biomarkers of neurological damage have become invaluable to complement clinical data and provide more accurate diagnostics at early stages, other neurodegenerative diseases show similar alterations hindering the differential diagnosis. To solve that, the detection of the pathognomonic biomarker of disease, PrPSc, the aberrantly folded isoform of the prion protein, could be used. However, the amounts in easily accessible tissues or body fluids at pre-clinical or early clinical stages are extremely low for the standard detection methods. The solution comes from the recent development of in vitro prion propagation techniques, such as Protein Misfolding Cyclic Amplification (PMCA) and Real Time-Quaking Induced Conversion (RT-QuIC), which have been already applied to detect minute amounts of PrPSc in different matrixes and make early diagnosis of prion diseases feasible in a near future. Herein, the most relevant tissues and body fluids in which PrPSc has been detected in animals and humans are being reviewed, especially those in which cell-free prion propagation systems have been used with diagnostic purposes.Keywords
Funding Information
- Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España (AGL2015-65046-C2-1-R)
- Interreg (POCTEFA EFA148/16)
This publication has 346 references indexed in Scilit:
- Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt–Jakob diseaseBrain, 2013
- Sensitivity of protein misfolding cyclic amplification versus immunohistochemistry in ante-mortem detection of chronic wasting diseaseJournal of General Virology, 2012
- Sensitive and specific detection of sporadic Creutzfeldt–Jakob disease brain prion protein using real-time quaking-induced conversionJournal of General Virology, 2012
- Enhancement of protein misfolding cyclic amplification by using concentrated cellular prion protein sourceBiochemical and Biophysical Research Communications, 2009
- Human variant Creutzfeldt-Jakob disease and sheep scrapie PrPres detection using seeded conversion of recombinant prion proteinProtein Engineering, Design and Selection, 2009
- Prion proteins in subpopulations of white blood cells from patients with sporadic Creutzfeldt–Jakob diseaseLaboratory Investigation, 2009
- Faecal shedding, alimentary clearance and intestinal spread of prions in hamsters fed with scrapieVeterinary Research, 2008
- Detection of infectious prions in urineFEBS Letters, 2008
- Transmission and Detection of Prions in FecesThe Journal of Infectious Diseases, 2008
- Pathogenesis of bovine spongiform encephalopathy in sheepArchives of Virology, 2007